Brief: Ensysce Biosciences And Oncozenge Sign LoI For Development Of Bupizenge In The U.S.
Nov 28 (Reuters) - Oncozenge AB ONCOZ.ST :
* ENSYSCE BIOSCIENCES AND ONCOZENGE ANNOUNCE LETTER OF
INTENT FOR
THE CO-DEVELOPMENT OF BUPIZENGE™ IN THE UNITED STATES
Source text for Eikon: ID:nWkr54JvYH
Further company coverage: ONCOZ.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))